ZhuZhou QianJin Pharmaceutical Co Ltd Total Liabilities
ZhuZhou QianJin Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has total liabilities worth CN¥1.70 Billion CNY (≈ $248.69 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ZhuZhou QianJin Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2025)
Total liabilities of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2025. This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 600479 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of ZhuZhou QianJin Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mishra Dhatu Nigam Limited
NSE:MIDHANI
|
India | Rs16.89 Billion |
|
Zhejiang Jihua Group Co Ltd
SHG:603980
|
China | CN¥590.92 Million |
|
Zhejiang Jingxing Paper Joint Stock Co Ltd
SHE:002067
|
China | CN¥2.41 Billion |
|
Sirio Pharma
SHE:300791
|
China | CN¥3.07 Billion |
|
Eagle Bancorp Inc
NASDAQ:EGBN
|
USA | $9.36 Billion |
|
Changchun Zhiyuan New Energy Equipment Co. Ltd
SHE:300985
|
China | CN¥1.57 Billion |
|
Hangzhou Advance Gearbox Group Co Ltd
SHG:601177
|
China | CN¥2.46 Billion |
|
Hanma Technology Group Co Ltd
SHG:600375
|
China | CN¥5.28 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down ZhuZhou QianJin Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600479 total asset value.
Liquidity & Leverage Metrics
ZhuZhou QianJin Pharmaceutical Co Ltd Total Liabilities Ratios Explained
ZhuZhou QianJin Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ZhuZhou QianJin Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual total liabilities of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.61 Billion ≈ $236.11 Million |
+13.86% |
| 2024-12-31 | CN¥1.42 Billion ≈ $207.37 Million |
-14.12% |
| 2023-12-31 | CN¥1.65 Billion ≈ $241.47 Million |
-9.21% |
| 2022-12-31 | CN¥1.82 Billion ≈ $265.97 Million |
+33.61% |
| 2021-12-31 | CN¥1.36 Billion ≈ $199.06 Million |
-7.26% |
| 2020-12-31 | CN¥1.47 Billion ≈ $214.63 Million |
+24.03% |
| 2019-12-31 | CN¥1.18 Billion ≈ $173.05 Million |
+13.44% |
| 2018-12-31 | CN¥1.04 Billion ≈ $152.55 Million |
-0.31% |
| 2017-12-31 | CN¥1.05 Billion ≈ $153.02 Million |
+10.28% |
| 2016-12-31 | CN¥948.21 Million ≈ $138.75 Million |
+21.70% |
| 2015-12-31 | CN¥779.17 Million ≈ $114.02 Million |
-7.59% |
| 2014-12-31 | CN¥843.20 Million ≈ $123.39 Million |
+23.29% |
| 2013-12-31 | CN¥683.92 Million ≈ $100.08 Million |
+17.68% |
| 2012-12-31 | CN¥581.18 Million ≈ $85.04 Million |
+101.73% |
| 2011-12-31 | CN¥288.10 Million ≈ $42.16 Million |
+52.71% |
| 2010-12-31 | CN¥188.65 Million ≈ $27.61 Million |
-40.01% |
| 2009-12-31 | CN¥314.48 Million ≈ $46.02 Million |
+71.23% |
| 2008-12-31 | CN¥183.66 Million ≈ $26.87 Million |
-2.98% |
| 2007-12-31 | CN¥189.30 Million ≈ $27.70 Million |
+11.93% |
| 2006-12-31 | CN¥169.13 Million ≈ $24.75 Million |
-16.84% |
| 2005-12-31 | CN¥203.38 Million ≈ $29.76 Million |
+37.06% |
| 2004-12-31 | CN¥148.38 Million ≈ $21.71 Million |
-21.17% |
| 2003-12-31 | CN¥188.23 Million ≈ $27.54 Million |
+7.98% |
| 2002-12-31 | CN¥174.31 Million ≈ $25.51 Million |
-4.66% |
| 2001-12-31 | CN¥182.84 Million ≈ $26.76 Million |
-- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more